Metrion Biosciences will be attending the virtual ELRIG Drug Discovery 2020 meeting taking place between 6th and 16th October 2020. Please email info@metrionbiosciences.com if you wish to arrange a meeting with one of our attendees. Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge bio cluster, one of Europe’s largest bioscience [...]
Metrion Biosciences look forward to attending, presenting posters and exhibiting at the Virtual Safety Pharmacology Society (SPS) Annual Meeting to be held from 14th to 17th September 2020. Metrion will be located at Booth # 400 in the exhibits hall for the duration of the virtual event. Our collaborative poster with Nanion Technologies will be [...]
Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration to accelerate neuroscience-focused research Initial twelve month collaboration successfully identifies hit compounds and progresses into hit-to-lead optimisation phase Cambridge and London, UK, 03 December 2019: Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and LifeArc, a leading UK independent medical [...]
Metrion Biosciences will be attending ELRIG Drug Discovery 2019 to be held at the ACC Arena, Liverpool on 5th and 6th November 2019. Dr Marc Rogers, Chief Scientific Officer, will be presenting an ion channel drug discovery focused talk at 12.10-12.30 during the British Pharmacology Society track 'Targeting Ion Channels for Drug Discovery" which takes [...]
Metrion Biosciences' CSO Dr Marc Rogers will be presenting a drug discovery focused talk at the Pain and Migraine Therapeutics Summit in Washington DC on 23rd to 24th September 2019. Marc will also be available during both days of the conference to discuss Metrion's range of ion channel focused drug discovery services. If you would [...]
Metrion Biosciences' Dr Sophie Rose will be attending On Helix at the Cambridge Building, Babraham Research Campus on Tuesday 9th July and participating in the panel discussion ‘Communication of the Future’. Sophie will also be on hand both before and after the panel discussion to provide more information on Metrion's range of ion channel drug [...]
Sophie Rose will be attending the Milner Therapeutic Symposium hosted by the Milner Institute at the Corn Exchange Cambridge on Tuesday 25th June 2019. This symposium is an opportunity for scientists from academia and industry to discuss their latest research and its potential to be applied in pharma or biotech towards new treatments. Please email [...]
Metrion Biosciences will be attending the annual Ion Channel Modulation Symposium (ICMS) organised by Sophion Bioscience on Thursday 20th and Friday 21st June 2019. The meeting will take place at Clare College, Memorial Court, Cambridge. Metrion will be presenting a poster (title and presenter to be confirmed) and will also be attending the dinner on [...]
Metrion Biosciences' CEO Dr Andrew Southan and Sales and Marketing Manager Dr Sophie Rose will be attending Biotech Outsourcing Strategy in Basel, Switzerland on Wednesday 19th and Thursday 20th June 2019. Metrion have a ten minute presentation slot at 11.20-11.30 on Day 1 (Wednesday 19th June) during the Discovery Track: "Innovation and Excellence in Discovery [...]
Ion channels continue to rise in prominence in both academic and commercial areas. Metrion Biosciences, alongside Sophion Bioscience, Nanion Technologies, Evotec and SB Drug Discovery sponsored the “Ion Channels in Drug Discovery XIX” Satellite meeting held on Friday 1st March at the Baltimore Convention Centre, as part of the 63rd annual meeting of the Biophysical [...]
